Large-scale testing (Phase 3)Ended earlyNCT05178862
What this trial is testing
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
Who this might be right for
Candidiasis, InvasiveCandidemia
Scynexis, Inc. 68